• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ATP 触发的抗癌药物递送。

ATP-triggered anticancer drug delivery.

机构信息

1] Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill and North Carolina State University, Raleigh, North Carolina 27695, USA [2] Molecular Pharmaceutics Division, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA [3] State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, China.

Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill and North Carolina State University, Raleigh, North Carolina 27695, USA.

出版信息

Nat Commun. 2014 Mar 11;5:3364. doi: 10.1038/ncomms4364.

DOI:10.1038/ncomms4364
PMID:24618921
Abstract

Stimuli-triggered drug delivery systems have been increasingly used to promote physiological specificity and on-demand therapeutic efficacy of anticancer drugs. Here we utilize adenosine-5'-triphosphate (ATP) as a trigger for the controlled release of anticancer drugs. We demonstrate that polymeric nanocarriers functionalized with an ATP-binding aptamer-incorporated DNA motif can selectively release the intercalating doxorubicin via a conformational switch when in an ATP-rich environment. The half-maximal inhibitory concentration of ATP-responsive nanovehicles is 0.24 μM in MDA-MB-231 cells, a 3.6-fold increase in the cytotoxicity compared with that of non-ATP-responsive nanovehicles. Equipped with an outer shell crosslinked by hyaluronic acid, a specific tumour-targeting ligand, the ATP-responsive nanocarriers present an improvement in the chemotherapeutic inhibition of tumour growth using xenograft MDA-MB-231 tumour-bearing mice. This ATP-triggered drug release system provides a more sophisticated drug delivery system, which can differentiate ATP levels to facilitate the selective release of drugs.

摘要

刺激触发药物递送系统已被越来越多地用于提高抗癌药物的生理特异性和按需治疗效果。在这里,我们利用三磷酸腺苷 (ATP) 作为触发抗癌药物可控释放的信号。我们证明,通过将 ATP 结合适体整合到 DNA 基序中进行功能化的聚合物纳米载体,当处于富含 ATP 的环境中时,可通过构象开关选择性地释放嵌入的阿霉素。在 MDA-MB-231 细胞中,ATP 响应纳米载体的半最大抑制浓度为 0.24 μM,与非 ATP 响应纳米载体相比,细胞毒性增加了 3.6 倍。具有透明质酸交联的外壳的 ATP 响应纳米载体,一种特异性的肿瘤靶向配体,提高了荷异种 MDA-MB-231 肿瘤小鼠的化疗抑制肿瘤生长的效果。这种 ATP 触发的药物释放系统提供了一种更复杂的药物递送系统,可以区分 ATP 水平以促进药物的选择性释放。

相似文献

1
ATP-triggered anticancer drug delivery.ATP 触发的抗癌药物递送。
Nat Commun. 2014 Mar 11;5:3364. doi: 10.1038/ncomms4364.
2
ATP/pH Dual Responsive Nanoparticle with d-[des-Arg ]Kallidin Mediated Efficient In Vivo Targeting Drug Delivery.具有 d-[des-Arg ]缓激肽介导的高效体内靶向递药作用的 ATP/pH 双重响应纳米粒子。
Small. 2017 Jan;13(3). doi: 10.1002/smll.201602494. Epub 2016 Oct 24.
3
ATP-Responsive and Near-Infrared-Emissive Nanocarriers for Anticancer Drug Delivery and Real-Time Imaging.用于抗癌药物递送和实时成像的ATP响应型近红外发射纳米载体
Theranostics. 2016 Apr 28;6(7):1053-64. doi: 10.7150/thno.14843. eCollection 2016.
4
ATP-responsive DNA-graphene hybrid nanoaggregates for anticancer drug delivery.用于抗癌药物递送的ATP响应性DNA-石墨烯杂化纳米聚集体
Biomaterials. 2015 May;50:67-74. doi: 10.1016/j.biomaterials.2015.01.053. Epub 2015 Feb 14.
5
Aptamer/Graphene Quantum Dots Nanocomposite Capped Fluorescent Mesoporous Silica Nanoparticles for Intracellular Drug Delivery and Real-Time Monitoring of Drug Release.适配体/石墨烯量子点纳米复合材料包覆的荧光介孔硅纳米粒子用于细胞内药物递送和药物释放的实时监测。
Anal Chem. 2015 Dec 1;87(23):11739-45. doi: 10.1021/acs.analchem.5b03131. Epub 2015 Nov 10.
6
Zwitterionic nanoparticles constructed with well-defined reduction-responsive shell and pH-sensitive core for "spatiotemporally pinpointed" drug delivery.构建具有明确的还原响应性外壳和pH敏感性核心的两性离子纳米颗粒用于“时空精准”药物递送。
ACS Appl Mater Interfaces. 2014 Aug 27;6(16):14631-43. doi: 10.1021/am503974y. Epub 2014 Aug 13.
7
ROS-triggered and regenerating anticancer nanosystem: an effective strategy to subdue tumor's multidrug resistance.ROS 触发的再生型抗癌纳米系统:克服肿瘤多药耐药性的有效策略。
J Control Release. 2014 Dec 28;196:370-83. doi: 10.1016/j.jconrel.2014.09.020. Epub 2014 Sep 30.
8
Bioreducible shell-cross-linked hyaluronic acid nanoparticles for tumor-targeted drug delivery.用于肿瘤靶向给药的生物可还原壳交联透明质酸纳米颗粒。
Biomacromolecules. 2015 Feb 9;16(2):447-56. doi: 10.1021/bm5017755. Epub 2015 Jan 7.
9
Toward the next-generation nanomedicines: design of multifunctional multiblock polyurethanes for effective cancer treatment.迈向新一代纳米药物:多功能多嵌段聚氨酯的设计用于有效治疗癌症。
ACS Nano. 2013 Mar 26;7(3):1918-28. doi: 10.1021/nn4002769. Epub 2013 Feb 19.
10
AS1411 aptamer and folic acid functionalized pH-responsive ATRP fabricated pPEGMA-PCL-pPEGMA polymeric nanoparticles for targeted drug delivery in cancer therapy.AS1411 适体和叶酸功能化 pH 响应原子转移自由基聚合制备 pPEGMA-PCL-pPEGMA 聚合物胶束用于癌症治疗的靶向药物传递。
Biomacromolecules. 2014 May 12;15(5):1737-52. doi: 10.1021/bm5001263. Epub 2014 Apr 15.

引用本文的文献

1
Synergistic integration of extracellular vesicles and metal-organic frameworks: unlocking new opportunities in disease diagnosis and therapy.细胞外囊泡与金属有机框架的协同整合:为疾病诊断和治疗开启新机遇
Theranostics. 2025 Jul 28;15(16):8609-8638. doi: 10.7150/thno.113474. eCollection 2025.
2
Application of smart responsive nanomaterials in the theranostics of gastrointestinal malignancies: Current status and future perspectives.智能响应性纳米材料在胃肠道恶性肿瘤诊疗中的应用:现状与未来展望
Coord Chem Rev. 2025 Jul 15;535. doi: 10.1016/j.ccr.2025.216641. Epub 2025 Mar 29.
3
Stimuli-Responsive DNA Hydrogel Design Strategies for Biomedical Applications.
用于生物医学应用的刺激响应性DNA水凝胶设计策略
Biosensors (Basel). 2025 Jun 4;15(6):355. doi: 10.3390/bios15060355.
4
Leveraging adenosine triphosphate for cancer theranostics.利用三磷酸腺苷进行癌症诊疗。
Theranostics. 2025 Mar 24;15(10):4708-4733. doi: 10.7150/thno.106291. eCollection 2025.
5
Precisely Targeted Nanoparticles for CRISPR-Cas9 Delivery in Clinical Applications.用于临床应用中CRISPR-Cas9递送的精准靶向纳米颗粒
Nanomaterials (Basel). 2025 Apr 2;15(7):540. doi: 10.3390/nano15070540.
6
Functional Nucleic-Acid-Decorated Spherical Nanoparticles: Preparation Strategies and Current Applications in Cancer Therapy.功能核酸修饰的球形纳米颗粒:制备策略及其在癌症治疗中的当前应用
Small Sci. 2021 Feb 9;1(3):2000056. doi: 10.1002/smsc.202000056. eCollection 2021 Mar.
7
Tumor microenvironment: recent advances in understanding and its role in modulating cancer therapies.肿瘤微环境:理解方面的最新进展及其在调节癌症治疗中的作用
Med Oncol. 2025 Mar 18;42(4):117. doi: 10.1007/s12032-025-02641-4.
8
Enhancing immunotherapy with tumour-responsive nanomaterials.用肿瘤响应性纳米材料增强免疫疗法。
Nat Rev Clin Oncol. 2025 Apr;22(4):262-282. doi: 10.1038/s41571-025-01000-6. Epub 2025 Mar 6.
9
Metal-organic framework-based smart stimuli-responsive drug delivery systems for cancer therapy: advances, challenges, and future perspectives.用于癌症治疗的基于金属有机框架的智能刺激响应型药物递送系统:进展、挑战与未来展望
J Nanobiotechnology. 2025 Feb 28;23(1):157. doi: 10.1186/s12951-025-03252-x.
10
Genetically engineered biomimetic ATP-responsive nanozyme for the treatment of cardiac fibrosis.用于治疗心脏纤维化的基因工程仿生ATP响应纳米酶
J Nanobiotechnology. 2025 Jan 9;23(1):10. doi: 10.1186/s12951-024-03083-2.